Tag: Medical

  • Universal Health Services Inc Valuation – April 2019 #UHS

    Universal Health Services Inc Valuation – April 2019 #UHS

    Universal Health Services, Inc. Class B qualifies for both the Defensive Investor and the Enterprising Investor. The Defensive Investor is only initially concerned with the low current ratio.

  • Dentsply Sirona Inc Valuation – March 2019 #XRAY

    Dentsply Sirona Inc Valuation – March 2019 #XRAY

    DENTSPLY SIRONA Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, and the high PEmg and PB ratios.

  • McKesson Corp Valuation – March 2019 #MCK

    McKesson Corp Valuation – March 2019 #MCK

    McKesson Corporation qualifies for both the Defensive Investor and the Enterprising Investor. The Defensive Investor is only initially concerned with the low current ratio.

  • IDEXX Laboratories Inc Valuation – March 2019 #IDXX

    IDEXX Laboratories Inc Valuation – March 2019 #IDXX

    IDEXX Laboratories, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, poor dividend history, and the high PEmg and PB ratios.

  • Hologic Inc Valuation – March 2019 #HOLX

    Hologic Inc Valuation – March 2019 #HOLX

    Hologic, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

  • Mettler-Toledo International Inc Valuation – March 2019 #MTD

    Mettler-Toledo International Inc Valuation – March 2019 #MTD

    Mettler-Toledo International Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, poor dividend history, and the high PEmg and PB ratios.

  • DaVita Inc Valuation – March 2019 #DVA

    DaVita Inc Valuation – March 2019 #DVA

    Davita Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the poor dividend history.

  • Danaher Corp Valuation – March 2019 #DHR

    Danaher Corp Valuation – March 2019 #DHR

    Danaher Corporation does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • Agilent Technologies Inc Valuation – March 2019 #A

    Agilent Technologies Inc Valuation – March 2019 #A

    Agilent Technologies Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

  • ResMed Inc Valuation – March 2019 #RMD

    ResMed Inc Valuation – March 2019 #RMD

    ResMed Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the poor dividend history, and the high PEmg and PB ratios.